The NNE-CTR is MOVING FORWARD!
Our NNE-CTR funding has been renewed for five years, reflecting effectiveness of our members and leadership. The NIH review panel recognized the approaches that our program has developed to address the health and healthcare challenges in our predominantly rural northern New England population. There was appreciation for the contributions that the NNE-CTR has made to increase capabilities in addressing the prevention, early detection, treatment, and survivorship with chronic diseases that include cancer, substance abuse disorders, food insecurity, obesity, diabetes, and cardiovascular disease. The pivotal role of the NNE-CTR in maximizing accessibility to health and healthcare during the COVID-19 pandemic was considered exemplary with practices and policies that provided broad-based benefits.
Moving forward, we are committed to strengthening our partnerships with the Northern New England Practice-Based Research Network Co-Op (NNE PBRN Co-Op) to reinforce collaborations of primary care colleagues with scientists and physician-investigators in academic medical centers for engagement in health and healthcare initiatives in Vermont, Maine and New Hampshire. We are expanding our resources for guidance, education and training in clinical and translational investigation with emphasis on support for professional development and research at all stages of the career continuum. We are enhancing our capabilities for mechanistic, translational, clinical, health services, and implementation investigation, as well as clinical trials. The NNE-CTR community outreach and engagement programs, with resources that focus on bidirectional communication with regional stakeholders, will be a centerpiece as we move forward. A priority of the NNE-CTR will be responsiveness to disparities in both health and healthcare access for New Englanders that leverage capabilities for maximizing health equity, diversity, and inclusion. It was acknowledged by the reviewers that our NNE-CTR provides state-of-the-art instrumentation and technical support with guidance in genomics, proteomics, multispectral cellular imaging, metabolomics, and bioinformatics to support advances in precision/genomic medicine.
We have valued collaborations with our State Departments of Health that are increasingly important for integration of public health strategies and resources for regionally relevant programs that are responsive to the requirements of underserved populations. These collaborations were essential for NNE-CTR effectiveness during the COVID-19 pandemic and will be all the more important as we emerge from the pandemic and reestablish momentum in the prevention, early detection, treatment, and survivorship with chronic diseases.
We are very appreciative of the contributions from our NNE-CTR members and the dedication of our exceptionally competent leadership and administrative support team. Gordon Jensen, and now Renee Stapleton, with Tom Gridley have been instrumental as our partners for strategic planning and program development. Our core leadership have provided incredibly valuable support for NNE-CTR members to develop clinical and translational research initiatives that include pilot projects and programs supported by NIH, USDA, HRSA, and PCORI. Meredith Oestreicher and Michele Locker, initially Jennifer Smith and now Sheila Clifford-Bova complete the team.
To us, addressing the northern New England health and healthcare challenges is not an option but a responsibility. And we are appreciative for the resources and the opportunity we have to collaboratively work towards making a difference in regional health and healthcare over the next five years.
Thank you for your engagement.
Gary & Cliff